Top Trending #HumpDay News & Stories

Top Trending #HumpDay News & Stories

0 2349

$IMLFF to Present at the 29th Annual ROTH Conference

 

InMed Pharmaceuticals, Inc.(“InMed”) (CSE: IN; OTCQB: IMLFF) announces today that Eric A. Adams, Chief Executive Officer, will be presenting to U.S. institutional investors at the 29th Annual ROTH Conference, which is being held March 12-15, 2017, at the Ritz Carlton, Laguna Niguel, California.


Click Here Now To Read Full Release


List Of CBD Stocks To Watch

For a fairly new market, the Marijuana industry has been embracing unprecedented levels of growth over the past decade. The surge had every investor frantically logging in to their e-trade accounts trying to find the next big Marijuana stock. Although the previous focus of the medical companies was based on the harvesting of the THC component of Marijuana, many have recently discovered the true health benefits of Cannabidiol; a part of the plant that only holds its health benefits and not those that get you ‘high.’

Based on the attention the industry is getting, it seems fitting to highlight some of the most active CBD stocks to watch this year. Here are several CBD stocks on our own list…[continue reading]


Click Here To Read Full Article


 

$RMHB Acquire Upstate New York Facility as a Bottling Plant

Rocky Mountain High Brands, Inc. (RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline water announced today that it has entered into an agreement with L and H Resort Systems to acquire a former Catskill Mountain resort facility located on a natural spring. The Company plans to repurpose the resort into a Bottling and Canning Plant for Rocky Mountain High Brands…[continue reading]


Click Here Now To Read Full PR


Pursuant to an agreement between MAPH and InMedPharmaceuticals., we were hired for a period beginning February 24 2017 and ending April 24, 2017 to publicly disseminate information about (IMLFF) including on the Website and other media including Facebook and Twitter. We are being paid $40,000 (CASH) for and were paid “250,000” shares of restricted common shares of InMed Pharmaceuticals.We may buy or sell additional shares of (IMLFF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

NO COMMENTS

Leave a Reply